Interleukin 7 (IL-7) and T cell antigen receptor signals have been proposed to be the main drivers of homeostatic T cell proliferation. However, it is not known why CD4 + T cells undergo less-efficient homeostatic proliferation than CD8 + T cells do.
The regeneration of T cells in lymphopenic hosts can occur through thymopoiesis or thymic-independent homeostatic proliferation of peripheral T cells. Thymic output diminishes early in life and, in clinical settings associated with lymphocyte depletion, is further limited by thymotoxic insults such as cytotoxic chemotherapy, radiotherapy, infection with human immunodeficiency virus, and graft-versus-host disease [1] [2] [3] . As a result, humans experiencing T cell depletion often rely on homeostatic proliferation to restore peripheral T cell populations. Homeostatic proliferation efficiently regenerates peripheral CD8 + lymphocyte pools but inefficiently regenerates CD4 + T cell populations [4] [5] [6] . The present models of T cell homeostasis do not explain the molecular and/or cellular basis for this difference in the ability to regenerate CD4 + and CD8 + T cell pools.
Published mouse studies have concluded that homeostatic proliferation of naive CD8 + and CD4 + T cells requires T cell antigen receptor (TCR) signals delivered by peptides presented by major histocompatibility complex (MHC) class I and class II molecules, respectively [7] [8] [9] . In addition, naive CD4 + and CD8 + T cells fail to proliferate and disappear when transferred into recipients lacking endogenous interleukin 7 (IL-7) 10, 11 , and short-term administration of pharmacological doses of IL-7 increases the homeostatic proliferation of CD4 + and CD8 + lymphocytes [12] [13] [14] . Such findings support a model in which TCR signaling and IL-7 act as the main drivers of the homeostatic proliferation of naive T cells. At the same time, the biological effect of IL-7, at least in terms of proliferation, is greater on CD8 + T cells than on CD4 + T cells 14, 15 , and high IL-7 concentrations in lymphopenic humans show stronger inverse correlations with CD4 + T cell numbers than with CD8 + T cell numbers 16, 17 . The last findings raise the possibility that chronic stimulation with excessive IL-7 could negatively affect the homeostatic proliferation of CD4 + T cells and could potentially contribute to the differences in the regeneration of CD4 + versus CD8 + T cells. Here we sought to identify factors limiting the homeostatic proliferation of naive CD4 + T cells during lymphopenia, with a chief focus on the potential function of IL-7. We demonstrate that IL-7 concentrations became higher in lymphopenic hosts because of diminished use of IL-7. Chronically high systemic IL-7 concentrations diminished the capacity of DCs expressing IL-7 receptor-a (IL-7Ra; A001267) to support the homeostatic population expansion of CD4 + cells at least in part through IL-7-mediated downregulation of the expression of MHC class II. Thus, IL-7 signaling in DCs potently regulates expansion of CD4 + populations in vivo.
RESULTS
Higher IL-7 concentrations in lymphopenic mice In humans [16] [17] [18] and other primates 19 , lymphopenia is associated with higher concentrations of IL-7 in the circulation and in tissues. However, whether a similar link between lymphopenia and IL-7 exists in mice is not known. Using commercial enzyme-linked immunosorbent assay kits that can measure IL-7 concentrations as low as 30 pg/ml, we detected IL-7 concentrations of approximately 40 pg/ml in the serum of IL-7Ra-deficient (Il7r -/-) mice, but we did not detect IL-7 in the serum of mice deficient in recombination-activating gene 1 (Rag1 -/-) or wild-type mice (data not shown). With a bioassay based on the proliferation of an IL-7-dependent cell line that can be used to reliably measure IL-7 concentrations as low as 10 pg/ml (Supplementary Fig. 1a online) , we detected IL-7 concentrations of 10 pg/ml, 25 pg/ml and 40 pg/ml in the serum of wild-type, Rag1 -/and Il7r -/mice, respectively ( Fig. 1a) . A second bioassay based on IL-7-mediated downregulation of IL-7Ra 20 demonstrated that congenic lymphocytes transferred into Rag1 -/or Il7r -/recipient mice ( Fig. 1b and data not shown) had much lower surface expression of IL-7Ra than did lymphocytes transferred into wild-type or Il7 -/recipients. This was not due to proliferation-associated downregulation of IL-7Ra in response to lymphopenia, as staining with the cytosolic dye CFSE showed no proliferation at the 24-hour time point used for these studies (data not shown); this IL-7Ra downregulation was also not due to IL-7-mediated blockade of the binding of antibody to IL-7Ra (anti-IL-7Ra; Supplementary Fig. 1b ). Lower expression of IL-7Ra protein was accompanied by diminished expression of IL-7Ra mRNA, as reported before 20 (data not shown). These data confirm that lymphopenic mice, like lymphopenic primates [16] [17] [18] [19] , have higher IL-7 concentrations. In addition, these findings show that IL-7 concentrations are higher in Il7r -/mice than in similarly lymphopenic Rag1 -/mice, which raises the possibility that IL-7Ra contributes to the regulation of IL-7 production.
IL-7Ra-mediated IL-7 feedback loop
The different IL-7 concentrations in wild-type, Rag1 -/and Il7r -/mice raised the possibility that IL-7 production is regulated by lymphopenia and/or IL-7Ra. Notably, however, quantitative RT-PCR demonstrated that splenic stromal cells from Rag1 -/mice had significantly lower expression of IL-7 mRNA than did wild-type splenic stromal cells ( Fig. 1c ). We obtained similar results with spleen and lymph node homogenates from mice with severe combined immunodeficiency versus wild-type mice (data not shown). Il7r -/splenic stromal cells and wild-type splenic stroma expressed similar amounts of IL-7 mRNA ( Fig. 1c) , which was consistent with the finding that Il7r -/mice had more serum IL-7 than Rag1 -/mice had ( Fig. 1a) and suggested that IL-7 signaling through IL-7Ra on lymphoid stroma modulates IL-7 production. To test that hypothesis, we measured IL-7 transcripts after administering recombinant human IL-7 to wild-type and Il7r -/mice. This resulted in significantly less IL-7 mRNA expression in wild-type mice but not in Il7r -/mice ( Fig. 1d) . Similarly, inhibition of IL-7 signaling with blocking IL-7-and IL-7Ra-specific monoclonal antibodies enhanced the expression of IL-7 mRNA in Rag1 -/mice ( Fig. 1e) . These results indicate that IL-7 signaling on lymphoid stromal populations is involved in the regulation of IL-7 production in vivo.
As stromal IL-7Ra expression has been reported only on human marrow stromal populations 21, 22 , we examined IL-7Ra expression in the capsule of the spleen, an area rich in splenic stromal cells. For this, we used mice engineered to express green fluorescent protein (GFP) under regulation of the Il7r promoter. These mice had substantial GFP expression in the splenic capsule ( Fig. 1f) , which confirmed Il7r transcription in this compartment. These findings demonstrate the existence of an IL-7Ra-mediated feedback loop that regulates IL-7 production. In addition, these data indicate that high expression of IL-7 protein in lymphopenic hosts results from the accumulation of IL-7 rather than more production of IL-7. Paradoxically, IL-7 mRNA production diminished during lymphopenia.
Abundant IL-7 promotes CD8 + but not CD4 + T cell proliferation To compare the ability of lymphopenia to drive the homeostatic proliferation of CD4 + versus CD8 + T cell populations, we labeled lymph node-derived T cells with CFSE and transferred them into Rag1 -/recipient mice. Within 7 d, most CD8 + T cells proliferated but most CD4 + T cells did not divide ( Fig. 2a,b ). As reported before, the proliferation of polyclonal CD4 + populations in Rag1 -/mice was limited to a subset of rapidly dividing cells, which have been described as IL-7-independent cells cross-reactive with environmental antigens and probably derived from memory CD4 + T cells 23, 24 . Consistent with that hypothesis, we detected minimal proliferation of polyclonal CD4 + T cell populations depleted of CD44 hi cells in Rag1 -/mice (Supplementary Fig. 2 online) . Similarly, an exclusively naive CD4 + population composed of T cells from TCR-transgenic Marilyn mice, which bear a single TCR restricted for MHC class II in association with Dby, an antigen contained in the male HY complex, did not proliferate in female Rag1 -/mice; this finding agrees with published findings obtained with CD4 + T cells bearing other TCR transgenes 25, 26 ( Fig. 2c) . Therefore, lymphopenia efficiently supports the homeostatic proliferation of bulk CD8 + T cells but not CD4 + T cells and induces essentially no proliferation of naive CD4 + cells.
The present models hold that IL-7 signaling is regulated by cytokine availability in vivo 20 . Therefore, one potential explanation for our findings is that CD8 + T cells have a competitive advantage relative to CD4 + T cells for limiting amounts of systemic IL-7, perhaps as a result of different IL-7Ra expression. We could find no evidence to support that conclusion, as the homeostatic proliferation of CD4 + T cells did not increase after depletion of CD8 + T cells (data not shown). We also did not find different expression IL-7Ra or the common g-chain on CD8 + cells versus CD4 + cells (data not shown) or different phosphorylation of the transcription factor STAT5 in CD4 + T cells versus CD8 + T cells exposed to limiting concentrations of IL-7 ex vivo (Supplementary Fig. 3 online) . Furthermore, transfer of lymph node T cells to mice receiving pharmacological doses of recombinant human IL-7, which generate serum concentrations of human IL-7 one log greater than the IL-7 concentrations in lymphopenic mice 27 , resulted in efficient proliferation of CD8 + T cells but not of polyclonal or Marilyn CD4 + T cells ( Fig. 2d-f ). Notably, despite the minimal proliferation of CD4 + T cells, we found substantial accumulation of polyclonal CD4 + T cells ( Fig. 2e ) and Marilyn CD4 + T cells (data not shown) in IL-7treated mice; these findings suggest that IL-7 may enhance the survival of CD4 + T cells and thus may hold therapeutic utility in vivo despite limited proliferative effects. We obtained similar results when we administered IL-7 to Rag1 -/recipient mice (data not shown). Therefore, we conclude that exposure to high systemic concentrations of IL-7, as occurs in lymphopenic mice or after the administration of pharmacological doses of IL-7, 'preferentially' expands CD8 + T cell populations.
In contrast, when we increased antigen-presenting cell (APC) numbers by treating mice with recombinant human ligand for the receptor tyrosine kinase Flt3, CD4 + T cells underwent substantial proliferation ( Supplementary Fig. 4 online). This effect was much lower in CD11c-DTR bone marrow-chimeric mice, in which diphtheria toxin induces depletion of CD11c hi cells 28 . Therefore, accessibility to APCs rather than the availability of systemic IL-7 seems to be a chief factor that limits the homeostatic proliferation of CD4 + T cells during lymphopenia.
Function of IL-7 signaling in bone marrow-derived cells
The results reported above and published studies [29] [30] [31] [32] [33] demonstrating that modulation of APC numbers induces the homeostatic proliferation of CD4 + T cells emphasize the influence of MHC class II-positive DCs on the peripheral CD4 + T cell niche. However, several studies have also indicated that IL-7 is necessary for the homeostatic proliferation of CD4 + T cells 10, 34, 35 . To investigate whether IL-7 produced by DCs is necessary or sufficient to support that proliferation, we transferred CFSE-labeled T cells into chimeric mice engineered so that IL-7 production was limited to radioresistant stroma or radiosensitive bone marrow-derived cells ( Supplementary Fig. 5 online). Despite lymphopenia in all groups, chimeras lacking IL-7 entirely (Il7 -/recipients of Il7 -/bone marrow) failed to support CD4 + or CD8 + T cell homeostatic proliferation. However, IL-7 production by both stroma and bone marrow-derived cells (in Rag1 -/recipients of Rag1 -/bone marrow) supported substantial homeostatic proliferation of CD8 + T cells but limited homeostatic proliferation of CD4 + T cells. Unexpectedly, the absence of stromal cell-derived IL-7 in the presence of bone marrow-derived IL-7 (in Il7 -/recipients of Rag1 -/bone marrow) resulted in massive homeostatic proliferation of CD4 + T cells, whereas chimeras that produced IL-7 exclusively from radioresistant stromal cells (wild-type recipients that underwent thymectomy and were then given Il7 -/bone marrow) failed to support the homeostatic proliferation of CD4 + T cells (Fig. 3b,c) . To confirm that the CD4 + T cell proliferation observed was indeed homeostatic and not antigen driven 24 , we repeated this experiment with Marilyn CD4 + cells. The results confirmed that naive CD4 + T cells did not undergo homeostatic proliferation when IL-7 was produced by both stroma and bone marrow-derived cells or exclusively by the stroma; however, proliferation was supported when IL-7 production was limited to the bone marrowderived compartment ( Fig. 3c,d) . Therefore, bone marrow-derived IL-7 is sufficient to support the homeostatic proliferation of CD4 + T cells during lymphopenia, whereas stromal cell-derived IL-7 paradoxically diminishes such proliferation. Settings in which IL-7 production is limited to bone marrow-derived cells facilitate maximal homeostatic proliferation of CD4 + T cells.
As hosts with higher concentrations of IL-7 derived from stroma showed limited homeostatic proliferation of CD4 + T cells ( Fig. 3) , we hypothesized that IL-7 signaling on IL-7Ra + hematopoietic cells could regulate the homeostatic proliferation of CD4 + T cells in vivo. To test our hypothesis, we measured this proliferation in bone marrow chimeras engineered so that bone marrow-derived cells could not receive IL-7 signals (Rag1 -/recipients of Il7r -/bone marrow or common g-chain-deficient (Il2rg -/-) bone marrow). Notably, Il7r -/and Il2rg -/bone marrow supported considerable homeostatic proliferation of Marilyn CD4 + T cells ( Fig. 4a ) and polyclonal CD4 + T cells (Fig. 4b,c) . Similarly, chimeras in which bone marrowderived cells lacked 'downstream' mediators of IL-7 signaling (Rag1 -/recipients of Stat5a -/-Stat5b -/bone marrow) also supported robust homeostatic proliferation of polyclonal CD4 + T cell populations (Fig. 4b,c ). These results demonstrate that IL-7 signaling through IL-7Ra and STAT5 in bone marrow-derived cells inhibits the homeostatic proliferation of CD4 + T cells. Notably, the robust homeostatic proliferation of CD4 + T cells noted in the absence of common g-chain signaling on APCs ruled out the possibility that thymic stromal lymphopoietin mediated this inhibitory effect.
Published studies have concluded that stroma-derived IL-7 is necessary and sufficient to support CD8 + T cell homeostatic proliferation 10 ; however, the results presented here have shown that bone marrow-derived IL-7 was sufficient to support the homeostatic proliferation of CD4 + T cells. IL-7 is not produced by T cells, B cells or natural killer cells but is produced by DCs and macrophages, albeit in smaller amounts than that produced by lymphoid stroma [36] [37] [38] . To determine whether bone marrow-derived IL-7 can be delivered in trans with MHC class II signals to CD4 + T cells or whether IL-7 production and MHC class II must be present on the Il7 -/and Rag1 -/bone marrow) showed robust homeostatic proliferation of CD4 + T cells, whereas those expressing MHC class II and IL-7 exclusively in trans (Il7 -/recipients of MHC class II-deficient and Il7 -/bone marrow) showed minimal proliferation (Fig. 4d) .
These results confirm the critical function of MHC class II in supporting the homeostatic proliferation of CD4 + T cells, support a model in which access to a cells producing IL-7 and expressing MHC class II is required for this proliferation, and demonstrate that the presence of stromal cell-derived IL-7 impairs this proliferation.
IL-7Ra signaling regulates DC expression of MHC class II
Given findings indicating the involvement of MHC class II in the homeostatic proliferation of CD4 + T cells and the evidence presented above demonstrating that IL-7 signaling on bone marrow-derived cells regulates the homeostatic proliferation of CD4 + T cells, we sought to evaluate IL-7Ra expression on DC subsets by measuring IL-7Ra mRNA transcripts in electronically sorted splenocyte subpopulations. DCs expressed less IL-7Ra mRNA than T cells did, but among the various DC subsets, CD11b -CD11c + DCs had the most abundant expression of IL-7Ra transcripts ( Supplementary Fig. 6 online) .
Using splenocytes from mice expressing GFP under control of the Il7r promoter, we confirmed that a sizable fraction of CD11b -CD11c + DCs expressed IL-7Ra ( Fig. 5a ) and demonstrated that most cells bearing the phenotype ascribed to plasmacytoid DCs (B220 + CD11b -CD11c + MHC class II positive) also expressed IL-7Ra ( Fig. 5b) . We next evaluated the effects of IL-7 signaling on the expression of MHC class II in vivo on APCs. We found less expression of MHC class II on CD11b + CD11c -, CD11b + CD11c + and CD11b -CD11c + cells from Rag1 -/mice than on those from wild-type mice (Fig. 5c) , with CD11b -CD11c + B220 + cells having the lowest expression of MHC class II. Modulation of the expression of MHC class II was mediated by IL-7 signaling, as APCs from Il7r -/and Il7 -/mice, which are as lymphopenic as Rag1 -/mice, expressed wild-type amounts of MHC class II (Fig. 5d,e ). Furthermore, expression of MHC class II was restored on Rag1 -/-DCs transplanted into Il7 -/recipient mice but not on those transplanted into Il7r -/recipients ( Fig. 5f) . Thus, IL-7Ra + DCs consist mainly of CD11b -CD11c + B220 + MHC class II-positive cells, and high systemic IL-7 concentrations diminish the expression of MHC class II on IL-7Ra + DCs. Given the critical function of MHC class II-CD4 interactions in the homeostatic proliferation of CD4 + T cells, these results indicate IL-7-mediated downregulation of MHC class II is a likely mechanism through which IL-7Ra + DCs regulate the homeostatic proliferation of CD4 + T cells in vivo.
Feedback loop regulates DC IL-7 production
In addition to the effects of IL-7 signaling on the expression of MHC class II, it remained possible that other effects of IL-7Ra signaling on DCs contributed to the diminished homeostatic proliferation of CD4 + T cells noted in the presence of large amounts of stromal cell-derived IL-7. Given that IL-7 production exclusively by bone marrow-derived cells was necessary and sufficient to sustain the homeostatic proliferation of CD4 + T cells in Il7 -/recipient mice, we postulated that IL-7 production by DCs themselves might be physiologically relevant in vivo. Therefore, we sought to determine whether IL-7 signaling on DCs regulates IL-7 production by DCs as it does on stromal cells. Similar to results obtained with stromal cell preparations, IL-7 mRNA was less abundant in splenocytes from Rag1 -/mice ( Fig. 6a ) than in splenocytes from wild-type or Il7r -/mice, which demonstrated that IL-7Ra-mediated feedback also regulates non-stromal cell-derived production of IL-7. Among IL-7-producing DC subsets, we noted an inverse relationship between IL-7Ra expression and IL-7 production, such that IL-7 production was lower in the IL-7Ra + CD11b -CD11c + subset than in the IL-7Ra -/lo CD11b + CD11c + subset (Fig. 6b) . We found more cells with more abundant production of IL-7 in the DC region of the spleens of Il7r -/mice than in that of Rag1 -/or wild-type mice (Fig. 6c) . Thus, IL-7Ra signaling facilitates downregulation of the expression of MHC class II and production of IL-7 in DCs; these feedback loops could explain the detrimental effects of high systemic concentrations of IL-7 on the homeostatic proliferation of CD4 + T cells.
IL-7Ra signals in T cells regulate proliferation
In addition to changes in APC function, we reasoned that high systemic concentrations of IL-7 could also act directly on T cells to suppress their ability to undergo homeostatic proliferation. IL-7 signaling diminishes IL-7Ra expression 20 , and downmodulation of IL-7Ra on proliferating CD4 + cells in settings of high IL-7 concentrations could directly constrain IL-7-dependent homeostatic proliferation. Indeed, CD4 + and CD8 + T cells transferred into Rag1 -/mice had less IL-7Ra expression than did those transferred into Il7 -/mice ( Figs. 1b and 7a) . The degree of IL-7Ra downregulation was similar in CD4 + and CD8 + cells, which suggested that this effect was not responsible for the different homeostatic proliferation of CD4 + versus CD8 + cells (Fig. 2) . However, we also noted downregulation of the expression of the CD4 coreceptor, but not the CD8 coreceptor, on T cells transferred into Rag1 -/mice but not on those transferred into Il7 -/mice (Fig. 7a) . Therefore, diminished expression of IL-7Ra and/or CD4 coreceptor on T cells could also contribute to the inefficient homeostatic proliferation of CD4 + T cells in lymphopenic hosts with high systemic IL-7 concentrations. The effects of less expression of IL-7Ra and/or CD4 would be expected to act in synergy with the influence of diminished expression of MHC class II and IL-7 by dendritic cells in lymphopenic mice.
To assess the effect of IL-7 signaling on T cells versus APCs, we evaluated the homeostatic proliferation of wild-type CD4 + T cells transferred into Il7r -/mice, in which IL-7 signaling on APCs cannot be invoked to explain the constrained homeostatic proliferation of CD4 + T cells. Both polyclonal and Marilyn CD4 + T cells underwent much more homeostatic proliferation than did those of Rag1 -/mice (Fig. 7b ). Next we compared the effect of varying amounts of stromal cell-derived IL-7 on the homeostatic proliferation of wild-type CD4 + T cells transferred into bone marrow chimeras created such that APCs lacked IL-7Ra (and therefore were maximally supportive of the homeostatic proliferation of CD4 + T cells). Even when APCs lacked IL-7Ra, high systemic concentrations of IL-7 (in Il7r -/recipients) suppressed the homeostatic proliferation of CD4 + T cells; proliferation was greater and maximal in Rag1 -/and Il7 -/recipients, respectively (Fig. 7c,d) . Therefore, in addition to APCs, T cells are influenced by high systemic concentrations of IL-7.
To compare the relative dominance of IL-7 effects on APCs versus T cells, we used Il7r -/recipient mice (which had the maximum stromal cell-derived IL-7) and compared the population expansion of wild-type CD4 + cells in the presence or absence of IL-7 signaling in APCs. If the 'T cell-centric' effects of high systemic concentrations of IL-7 were the predominant force inhibiting the homeostatic proliferation of CD4 + T cells, minimal proliferation would occur in this system regardless of whether APCs were able to transmit IL-7 signals. However, wild-type CD4 + T cell proliferation was much higher in recipients of Il7r -/bone marrow than in recipients of Rag1 -/bone marrow ( Supplementary Fig. 7 online) . We conclude, therefore, that IL-7 signaling on APCs is the main regulator of the homeostatic proliferation of naive CD4 + T cells during lymphopenia.
DISCUSSION
Many clinical studies have demonstrated that lymphopenic insults are followed by relatively rapid normalization of CD8 + T cells through thymus-independent homeostatic proliferation, whereas chronic depletion of CD4 + T cells continues unless thymic function is present 1, 2, 6, 39, 40 . Moreover, although IL-7 has been suggested to be a driver of homeostatic proliferation, clinical studies have shown inverse relationships between systemic IL-7 concentrations and CD4 + T cell counts, which raises the possibility that large quantities of IL-7 negatively regulate CD4 + T cell homeostasis. Such an inhibitory effect would make sense, as IL-7 is continually available in lymphoid tissues and is abundant in the serum 17 , the IL-7 receptor complex is expressed on most T cells and IL-7 signals induce potent costimulation. Some system to prevent uncontrolled IL-7-mediated T cell proliferation in vivo must be in place. Studies have postulated that the effects of IL-7 are regulated by competition for limiting amounts of IL-7 and dynamic regulation of IL-7Ra expression on T cells 20 . However, here we have identified two previously unknown points at which IL-7 regulates CD4 + T cell homeostasis. First, we have shown that IL-7 production in vivo is tightly regulated by a simple feedback loop. When tissue IL-7 concentrations increased (for example, because of less use during lymphopenia or after injection of exogenous IL-7), IL-7 production diminished in both stromal cells and APCs. Second, we have shown that IL-7 signaling on APCs and, to a lesser extent, on T cells controlled the homeostatic population expansion of CD4 + cells in vivo.
The effects of IL-7 on IL-7Ra + APCs are probably manifold, but we found much less expression of MHC class II on IL-7Ra + DCs in the presence of more IL-7 in vivo and enhanced expression of MHC class II on IL-7Ra + DCs when IL-7 was absent. The transcription factor CIITA is required for the expression of MHC class II, and the mitogen-activated protein kinase p38 signaling pathway is a negative regulator of expression of the gene encoding CIITA 41 . IL-7 activates p38 (ref. 42) , and DCs grown in the presence of IL-7 have lower expression of MHC class II (ref. 43 ). Hence, we postulate that IL-7mediated downmodulation of the expression of MHC class II on IL-7Ra + DCs directly diminishes support for the homeostatic proliferation of CD4 + T cells. Consistent with that idea, we found that the population expansion of APCs via Flt3 ligand potently augmented the homeostatic proliferation of CD4 + T cells, further indicating that the availability of MHC class II-positive APCs is a principal factor that regulates the size of the peripheral CD4 + T cell niche. A substantial effect of expression of MHC class II is consistent with models invoking a critical influence of TCR stimulation on the homeostatic proliferation of CD4 + T cells 25 .
In addition to affecting the expression of MHC class II, IL-7 signaling may influence other attributes of IL-7Ra + DCs. Several reports have demonstrated that APCs produce IL-7 (refs. [36] [37] [38] 44) , but the biological relevance of this observation has not been explored. Our studies of Il7 -/hosts have shown that coexpression of IL-7 and MHC class II by the same APC was necessary to support the homeostatic proliferation of CD4 + T cells. This may relate to the relatively low frequency of IL-7Ra + DCs and/or the relatively small amount of IL-7 released by DCs, which would make it unlikely for naive CD4 + T cells to receive both signals simultaneously by different cells. Whether this requirement holds true during lymphopenia, when systemic IL-7 quantities increase, remains unknown. Indeed, it seems paradoxical to suggest that limiting amounts of IL-7 production by DCs regulate the homeostatic proliferation of CD4 + T cells if tissue quantities of IL-7 are high. However, such an effect could occur if tissue IL-7 is not as physiologically accessible to CD4 + T cells as it is to CD8 + T cells. Additional studies are needed to clarify the physiological function of APC-derived IL-7 and other potential 'downstream' effects of IL-7 signaling on IL-7Ra + DCs that might influence the homeostasis of CD4 + T cells.
The full physiological picture of the dynamic regulation of homeostatic expansion in vivo must also include IL-7-mediated modulation of IL-7Ra expression and coreceptor expression on T cells. Modulation of IL-7Ra expression on T cells contributes to constraint of the homeostatic proliferation of T cells in vivo, an effect that may be compounded by downmodulation of CD4 expression. Studies have demonstrated similar T cell-intrinsic forces that limit the homeostatic proliferation of CD4 + T cells, including IL-7-induced expression the receptor Fas (CD95), which predisposes T cells to activation-induced cell death 45 . Despite those findings, our results have shown that IL-7Ra signaling on APCs is the dominant axis through which IL-7 regulates CD4 + cell proliferation during lymphopenia.
Our findings have several clinical implications. First, they indicate involvement of plasmacytoid DCs, which represent most IL-7Ra + DCs, as a central regulator of the peripheral CD4 + T cell niche. We did not find IL-7Ra-mediated differences in APC numbers in the lymphopenic models presented here, but plasmacytoid DCs have been reported to be fewer in many clinical settings associated with CD4 + T cell depletion, such as infection with human immunodeficiency virus and after bone marrow transplantation [46] [47] [48] , which raises the possibility that depletion of IL-7Ra + DCs could contribute to chronic depletion of CD4 + T cells in humans. Second, our results allow the prediction that therapies that expand IL-7Ra + DC populations and/or modulate IL-7 signaling in APCs could improve immune reconstitution and potentially improve the effectiveness of adoptive cell therapy. Finally, it is possible that IL-7Ra signaling on APCs could control autoaggressive T cells in vivo in settings in which CD4 + populations mediate autoimmune pathology.
METHODS
Animals, bone marrow chimeras and cytokines. All experiments were approved by the Animal Care and Use Committee of the National Cancer Institute. Mice were C57BL/6Ncr females (CD45.1 + ) or, where indicated, C57BL/6Ly5.2 (CD45.2 + ) and were from the Animal Production Unit of the National Cancer Institute. B6;129S7-Rag1tm1Mom/J and B6.129-H2dlAb1-Ea/J mice were from Jackson Laboratories and C57BL/6 Rag1 -/-Il2rg -/mice were from Taconic Farms. C57BL/6 Il7 -/-, C57BL/6 Il7r -/-, C57BL/6 CD11c-DTR, C57BL/6 Stat5a -/-Stat5b -/and Rag1 -/-Marilyn mice were bred at National Institutes of Health facilities. Rag1 -/-Il7 -/mice were provided by S. Durum. For the generation of chimeric mice, bone marrow cells were obtained from both the tibias and femurs of donor mice. Recipient mice were irradiated with 1,300 rads (two doses of 650 rads) from a 137 Cs source and were injected intravenously with 1 Â 10 7 bone marrow cells. Then, 5 weeks later, chimeric mice were injected with congenic lymphocytes as specified ( Supplementary  Fig. 4 ). For depletion of CD11c hi cells during treatment with Flt3 ligand, chimeras were used, as repeated dosing with diphtheria toxin has been reported to be lethal to CD11c-DTR mice 26 , whereas bone marrow-chimeric mice are physically tolerant to such treatment, which allows continued depletion of the CD11c hi cell population. CD45.1 + C57BL/6 CD11c-DTR donor bone marrow cells were transplanted into lethally irradiated CD45.1 + C57BL/6 recipients. Then, 5 weeks after bone marrow transplantation, 1 Â 10 6 enriched lymph node T cells (CD45.2 + ) were adoptively transferred through the tail vein to the bone marrow chimeras. Recombinant human Flt3 ligand (10 mg) or PBS was administered for 14 d as a daily intraperitoneal injection. Among the Flt3 ligand-treated mice, some received diphtheria toxin treatment for ablation of CD11c hi cells. Mice were treated with diphtheria toxin (4 ng per kg body weight) on days 0, 4, 8 and 12. Mice were killed on day 14 and transferred lymphocytes were analyzed. Recombinant human IL-7 was supplied by Cytheris and was administered intraperitoneally at a dose of 10 mg per day for 12 consecutive days.
Measurement of IL-7. Serum was isolated from the retroorbital vein of anesthetized mice. Serum from four mice was pooled and was incubated with the IL-7-dependent cell line 2E8 (American Type Culture Collection). The 2E8 cells were plated at a density of 1 Â 10 5 cells per well in 96-well flat-bottomed microtiter plates with recombinant mouse IL-7 serially diluted as a standard or with unknown serum samples plated in triplicate; each well contained a final volume of 200 ml. Plates were incubated for 5 d at 37 1C and proliferation was measured through the addition of 1 mCi CFSE staining and adoptive transfer of lymphocytes. Lymph nodes from wild-type mice were homogenized and lymphocytes were enriched by negative selection with the Mouse Pan T Cell Isolation kit (Miltenyi Biotec). For enrichment of the naive lymphocyte fraction, enriched T cells were labeled with phycoerythrin-conjugated anti-CD44 (IM7; Pharmingen), then antiphycoerythrin microbeads were used for the removal of CD44 + cells (Miltenyi Biotec). Enriched T cells suspended at a density of 1 Â 10 7 cells per ml in PBS were incubated for 15 min at 37 1C with 1 ml of 5 mM CFSE (carboxyfluorescein diacetate succinimidyl diester; Molecular Probes). Cells were washed twice in PBS and were resuspended at a density of 2 Â 10 6 cells per ml. Recipient mice received 1 Â 10 6 CFSE-labeled polyclonal T cells and, where indicated, 0.5 Â 10 6 Marilyn T cells. After 7 d, mice were killed and CFSE content was analyzed with a dual-laser FACSCalibur (Becton Dickinson). FlowJo software (TreeStar) was used for all analyses. Calculation of the absolute number of cells recovered per spleen used a gate that included lymphoid and myeloid cells according to the forward-scatter and side-scatter profile.
Flow cytometry. Splenocytes were resuspended at a density of 10 Â 10 6 cells/ml in FACS buffer (0.2% (wt/vol) BSA and 0.1% (vol/vol) NaN 3 ) and were incubated for 30 min on ice with diluted monoclonal antibodies. Cells were then washed twice with FACS buffer and were resuspended in 1% (vol/vol) formalin in PBS. For GFP analysis, cells were resuspended in FACS buffer for immediate analysis. The following monoclonal antibodies were used (all from Pharmingen): phycoerythrin-anti-Vb6 (RR4-7); fluorescein isothiocyanateanti-CD3 (145-2C11); IgG1, k-chain (A19-3); phycoerythrin-anti-CD4 and peridinine chlorophyll protein complex-cyanine 5.5-anti-CD4 (RM4-5); phycoerythrin-anti-CD4; fluorescein isothiocyanate-anti-CD8 and peridinine chlorophyll protein complex-cyanine 5.5-anti-CD8 (Ly-2); allophycocyanin-anti-CD11b, phycoerythrin-anti-CD11b and peridinine chlorophyll protein complex-cyanine 5.5-anti-CD11b (M1/70); phycoerythrin-anti-CD11c (HL3); phycoerythrin-anti-CD44 (IM7); allophycocyanin-anti-CD45.1 (A20); peridinine chlorophyll protein complex-cyanine 5.5-anti-CD45.2 (104); allophycocyanin-anti-CD62L (MEL-14); phycoerythrin-anti-I-A and I-E (M5/114.15.2); fluorescein isothiocyanate-anti-B220 and phycoerythrin-anti-B220 (RA3 6B2); and phycoerythrin-conjugated antibody to STAT5 phosphorylated at Tyr694 (47) . Nonspecific binding was determined with the following isotype-matched control antibodies (all from Pharmingen): rat IgG2a (R35-95) conjugated to fluorescein isothiocyanate, phycoerythrin, peridinine chlorophyll protein complex-cyanine 5.5 or allophycocyanin; rat IgG2b (A95-1) conjugated to phycoerythrin, peridinine chlorophyll protein complex-cyanine 5.5 or allophycocyanin; mouse IgG1 (107.3); or Armenian hamster IgG1 (A19-3) conjugated to fluorescein isothiocyanate or phycoerythrin. Allophycocyanin-anti-CD127 (A7R34) was from eBioscience. Immunofluorescence was determined by automated multiparameter flow cytometry analyzing at least 1 Â 10 4 cells for purity and up to 1 Â 10 7 cells for CFSE analysis. For cell sorting, 1 Â 10 7 cells were labeled with the following antibodies (all from Pharmingen): fluorescein isothiocyanate-anti-B220, phycoerythrin-anti-I-A and I-E, peridinine chlorophyll protein complex-cyanine 5.5-anti-CD11b and allophycocyanin-anti-CD11c. A FACSAria (Beckton Dickinson) was used for cell sorting. For detection of phosphorylated STAT5, 1 Â 10 6 cells were first labeled with antibodies to cell surface antigens and then were washed with PBS supplemented with 2% (wt/vol) BSA. Cells were then incubated for 30 min at 37 1C with IL-7, then were immediately fixed and made permeable (Cytofix/Cytoperm; BD Pharmingen), and then were stained with antibody to phosphorylated STAT5 (47; Pharmingen).
Real time PCR. For analysis of stromal versus splenocyte RNA, whole spleens were sliced longitudinally with a sharp blade into two sections, then were opened and were washed with cold PBS; splenocytes were washed into a flask and the capsule was left clear of cell populations. The washed capsule, used as the stromal population, was then minced with scissors before RNA isolation. Recovered splenocytes were treated with red cell lysis buffer (Lonza), were washed and were passed through nylon mesh, then were used as the splenocyte fraction. Total RNA was extracted from the fractions with a FastRNA Pro Green kit (Q-Bio Gene), then was resuspended in 100 ml diethylpyrocarbonate-treated water. RNA concentrations were determined with a spectrophotometer. RNA (1 mg) was converted to cDNA with a 1st Strand cDNA Synthesis Kit for RT-PCR (Roche). A total volume of 20 ml was used for reverse transcription with random primers according to the manufacturer's instructions. An ABI-Prism 7000 Sequence Detection system was used for RT-PCR with the following cycle profile: 50 1C for 2 min, 95 1C for 10 min, and 40 cycles of 95 1C for 15 s and 60 1C for 1 min. A total volume of 50 ml was used for PCR amplification, containing 1 ml template DNA, 25 ml TaqMan Universal PCR Master Mix (Roche), 2.5 ml specific probes (described below) and 21.5 ml diethylpyrocarbonate-treated water. Results were quantified with a standard of doublestranded plasmid DNA containing the gene of interest and were normalized to those of the 'housekeeping' gene Hprt1 (encoding hypoxanthine guanine phosphoribosyl transferase); data are presented as copy number of the gene of interest per 1 Â 10 3 copies of Hprt1. Standard curves were created with tenfold dilutions from 100 pg to 100 ag. Samples were run in duplicate and the mean crossing point was compared with that of a set of standards run on the same plate. Probes were from TaqMan Gene Expression Assays (Applied Biosystems; Supplementary Table 1 online).
Immunostaining. Frozen tissues were sectioned at intervals of 5 mm and were fixed with acetone. After blockade for 30 min in PBS supplemented with 5% (vol/vol) goat serum, sections were incubated with primary antibodies. Mouse monoclonal anti-IL-7, isotype IgG2b (M25; Immunex), was used at a concentration of 20 mg/ml and rat anti-mouse CD45, isotype IgG2b (30-F11; BD Bioscience), used at a dilution of 1:20; antibodies were added for 30 min at 25 1C. Secondary antibodies Alexa Fluor 594-conjugated goat anti-rat IgG and AlexaFuor 488-conjugated goat anti-mouse IgG (at a dilution of 1:400) were applied to sections for 30 min in the dark at 25 1C, and sections were mounted with VectaShield containing the nuclear stain DAPI (4,6-diamidino-2-phenylindole; Vector Laboratories). Sections were viewed with a Zeiss
